Born in Chicago, Illinois

Hobbies include hiking, skiing, and general physical fitness

• Duke University: Bachelor of Science

• Washington University School of Medicine: Doctor of Medicine

• Weiss Memorial Hospital: Internship

• Duke University Eye Center: Ophthalmology Residency

• Kresge Eye Institute: Retina Surgery Fellowship

Board certified by the American Board of Ophthalmology

• Khurana RN, Appa SN, McCannel CA, Elman MJ, Wittenberg SE, Parks DJ, Ahmad S, Yeh S. Dexamethasone implant anterior chamber migration: Risk factors, complications, and management strategies. Ophthalmology. 2013; 121:67-71.
• Ahmad S, Bearelly S, Stinnett SS, Cooney MJ, Fekrat S. Photodynamic therapy for predominantly hemorrhagic choroidal neovascularization lesions in neovascular age related macular degeneration. American Journal of Ophthalmology. 2008; 145: 1052-7.
• Ahmad S, Wallace D, Herndon LW. Phthisis after endoscopic cyclophotocoagulation. Ophthalmic Surgery, Lasers, and Imaging. 2008; 39:407-8
• Harbour JW, Ahmad S, El-Bash M. Rate of resolution of exudative retinal detachment after plaque radiotherapy for uveal melanoma. Archives of Ophthalmology. 2002; 120(11):1463-9.
• Ahmad S, Teckman JH, Lueder GT. Corneal deposits associated with NTBC treatment. American Journal of Ophthalmology 2002; 134(2):266-8.
• Ahmad S, Rohrbaugh JW, Anokhin AP, Sirevaag EJ, Goebel JA. Effects of lifetime ethanol consumption on postural control: A computerized dynamic posturography study. Journal of Vestibular Research 2002; 12(1):53-64.

Principal Investigator:

A Prospective, Observational, Consecutive, Qualitative, Multicenter Study Assessing Eye Drop Administration

Assessing the Efficacy and Safety of DEXTENZA Sustained Release Dexamathasone 0.4 mg Insert(s) When Placed Within the Lower Eyelid Canaliculus or Both the Upper and Lower Canaliculi for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27-gauge Vitrectomy with Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated with Macular Pucker

150998-006 - Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients with Neovascular Age-Related Macular Degeneration (SEQUOIA) - Phase III

Sub-Investigator:

FVF4579g - Ranibizumab (Lucentis) with Subfoveal Neovascular Age-Related Macular Degeneration (HARBOR) - Phase III 

ACU301 - Bevasiranib Sodium with Exudative Age-Related Macular Degeneration (COBALT) - Phase III

VGFT-OD-0605 - VEGF Trap with Neovascular Age-Related Macular Degeneration (0605) - Phase III

VGFT-OD-0706 - VEGF Trap with Diabetic Macular Edema (0706) - Phase II

SCORE - Standard Care versus Corticosteroid for Retinal Vein Occlusion (SCORE) - Phase III

A Study of MK0140 in Diabetic Patients With Macular Edema (0140-001) - Phase II